Oxetoron

Jump to navigation Jump to search

Template:Oxetoron Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

Oxetoron
Ball-and-stick model
Ball-and-stick model
Clinical data
AHFS/Drugs.comInternational Drug Names
Pregnancy
category
  • AU: <! -- A / B1 / B2 / B3 / C / D / X -->
  • US: <! -- A / B / C / D / X-- >
ATC code
Legal status
Legal status
  • AU: <! -- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
  • CA: <! -- Schedule I, II, III, IV, V, VI, VII, VIII-- >
  • UK: <! -- GSL, P, POM, CD, or Class A, B, C-- >
  • US: <! -- OTC / Rx-only / Schedule I, II, III, IV, V-- >
Identifiers
CAS Number
PubChem CID
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC21H21NO2
Molar mass319.40 g/mol
3D model (JSmol)
  (verify)

Overview

It's chemical formula is 1-Propanamine, 3-benzofuro[3,2-c][1]benzoxepin-6(12H)-ylidene-N,N-dimethyl-. Oxetorone (USAN) is also known as Oxetorone Fumarate and Oxétorone . It's association with hyperprolactinemia has been described.[1]



Category

Oxetorone is an antimigraine agent.[2]


References

  1. Pradalier A (December 1996). "Hyperprolactinaemia and depression induced by oxetorone". Cephalalgia. 16 (8): 560–1. doi:10.1046/j.1468-2982.1996.1608560.x. PMID 8980859.
  2. Massiou H (2000). "[Prophylactic treatments of migraine]". Rev. Neurol. (Paris) (in French). 156 Suppl 4: 4S79–86. PMID 11139754.


Template:Antimigraine preparations